Close Menu

IPO

NEW YORK (GenomeWeb News) – Molecular cytology firm Veracyte has filed for an initial public offering in the US.
The South San Francisco, Calif.-based firm was founded in 2006 as Calderome, but changed its name to Veracyte in early 2008.

NEW YORK (GenomeWeb News) – Foundation Medicine's revenues through the first half of 2013 increased 363 percent year over year, the company said in its amended Form S-1 on Friday.

NEW YORK (GenomeWeb News) – Intrexon announced after the close of the market on Tuesday the closing of its initial public offering raising $184 million in gross proceeds.

NEW YORK (GenomeWeb News) – Intrexon's shares were up as much as 69 percent on its first day of trading on the New York Stock Exchange today.
In afternoon trading, shares of the Germantown, Md.-based synthetic biology firm remained sharply up at 50 percent at $24.05.

NEW YORK (GenomeWeb News) – Cellular Dynamics International said on Tuesday that it has closed its initial public offering, raising net proceeds of about $43 million.

NEW YORK (GenomeWeb News) – Cancer genomics firm Foundation Medicine has filed to go public, with a target goal of raising as much as $86.3 million.

NEW YORK (GenomeWeb News) – Intrexon today said that it plans to offer more than 8.3 million shares of its stock at between $14 and $16 per share in connection to its proposed initial public offering.

NEW YORK (GenomeWeb News) – Pacific Biosciences is closing in on a settlement over a class action lawsuit related to its initial public offering, the company has confirmed to GenomeWeb Daily News.

NEW YORK (GenomeWeb News) – Cellular Dynamics International has priced its initial public offering at $12 per share, the stem cell technology firm announced late Wednesday.

NEW YORK (GenomeWeb News) – Cellular Dynamics International today priced its planned initial public offering, expected to bring in up to $51 million in net proceeds.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.